When Burkitt first described the lymphoma which now bears his name, the most striking aspect of the tumour was the apparent dependence of its distribution on climatic factors. That the incidence of the tumour could be influenced by temperature and rainfall suggested at once that some biological agent was concerned in its causation, and the decision to seek possible aetiological viruses in Burkitt tumour material led directly to the discovery of the EB virus in 1964 (Epstein, Achong, and Barr, 1964) .
The EB virus was immediately recognized as belonging morphologically to the herpes group , and subsequent serological, immunological, and biological tests have amply confirmed that this virus is indeed a new and distinct member of the herpes group of viruses (Epstein and Achong, 1970) .
This review will cover the present status of the EB virus in relation to the tumours with which it has a marked association, namely, Burkitt's lymphoma and nasopharyngeal carcinoma, with special emphasis on its oncogenic potential. There are now well over 100 viruses which are known to cause virtually all kinds of cancer in every major group of animals including subhuman primates. The question naturally arises whether malignant tumours in man have a similar aetiology to the experimentally proven virus-induced neoplasms in animals or whether man is in some way unique in the animal kingdom and some special dispensation provides that no human malignant tumour should have a viral aetiology. If this latter proposition is deemed unwarrantable, then it becomes possible to speculate that some at least of human malignancies have a viral cause. Here, however, we come to a great impasse. In the case of animals, every example of an oncogenic virus has been demonstrated by the inoculation of the putative virus into animal hosts. In the case of man, this direct procedure being obviously impossible, indirect procedures have to be resorted to involving epidemiology, tissue culture, electron microscopy, cytology, serology, immunology, biochemistry, and inoculation into other species.
Let us consider what we know of the EB virus in the light of the four postulates proposed by Henle (1971) , which a suspected human tumour virus must 51 satisfy before it can be termed an oncogenic agent for man. These are. (Churchill and Biggs, 1967) and Herpes saimiri which causes a rapidly fatal reticulum cell sarcoma in owl monkeys and marmosets (Melendez, Hunt, Daniel, Garcia, and Fraser, 1969; Melendez, Daniel, Hunt, Fraser, Garcia, King, and Williamson, 1970) (Ahmed, Jensen, Slattery, Leech, and Schidlovsky, 1970; Rabson, O'Conor, Lorenz, Kirschstein, Legallais, and Tralka, 1971 ).
EB-VIRUS-DETERMINED ANTIGENS

Intracellular immunofluorescence
The original Henle indirect immunofluorescence test (Henle and Henle, 1966) (Nadkarni, Nadkami, Klein, Henle, Henle, and Clifford, 1970 (Klein, Clifford, Klein, and Stjernsward, 1966; Klein, Klein, and Clifford, 1967) that EB virus also determines the production of a non-virion but virus-mediated neo-antigen on the surface of Burkitt Zajac and Kohn (1970) , using the EB2 strain of Burkitt lymphoma cells which showed EB virus-specific immunofluorescence in 0 1-1 % of cells, obtained clones from singly seeded EB2 cells in the presence of EB virus antibodies, and all the 23 established sublines resembled the parent culture in the incidence of EB virus antigen-containing cells.
However, the final confirmation of the extremely close association ofEB viruswith Burkitt's lymphoma, nasopharyngeal carcinoma, and seemingly virus-free lymphoblastoid cell lines was established by Zur Hausen. The most characteristic feature of virustransformed cells is the presence of virus-specific nucleic acid within every tumour cell. In the case of the DNA oncogenic viruses the presence of viral nucleic acid in the transformed cell has been demonstrated by hybridization techniques. Therefore, if EB virus is indeed an oncogenic DNA virus it would be expected that its nucleic acid should be present in every tumour cell and every cell of a transformed lymphoblastoid established cell line. By means of DNA/DNA hybridization experiments Zur Hausen and first showed the presence of six EB viral genomes in each Raji cell, the Raji cell line being a Burkitt lymphoma line which up to that time had never shown the presence of EB virus either directly in the electron microscope or immunologically using the Henles' and the Kleins' immunofluorescence tests; Pope, Home, and Wetters (1969) had, however, reported that the Raji line did contain the EB virus-associated complement-fixing (S) antigen. Using the more sensitive technique of complementary RNA-DNA hybridization, Zur Hausen has now promoted the Raji line from the approximate number of six genome equivalents per cell to 40-55 (Zur Hausen and Schulte-Holthausen, 1971) . They also showed the presence of EB viral DNA in eight 'virus-free' lymphoblastoid human cell lines of various origins and proposed that the presence of the EB virus genome might be a general feature of all continuously growing human lymphoblastoid cell lines. These data have recently been confirmed by Nonoyama and Pagano (1971) .
In an extension of their work Zur Hausen, Schulte-Holthausen, Klein, Henle, Henle, Clifford, and Santesson (1970) (Pope, Horne, and Scott, 1968) (membrane, viral capsid, and early antigens). This is all in striking contrast to control groups of carcinoma of the hypopharynx or oropharynx or nasopharyngeal tumours other than carcinoma-these were either EB virusantibody negative or EB virus-antibody positive at low titres.
It is convenient to mention at this point that high EB virus-antibody titres were also seen in the sarcomatous form of Hodgkin's disease while in the paragranuloma type the antibody pattern was normal (Johansson, Klein, Henle, and Henle, 1970) .
Induction of Tumours in Non-human Primates or Other Animals by Inoculation of Virus
This last postulate has not been satisfied byEB virus and after eight years the search still continues for a suitable animal model, but under this heading we might conveniently examine some findings in the field of comparative lymphoma research which have added fresh pointers to the possible role of the herpestype EB virus in human neoplasia. There are now three herpes viruses that are known to be oncogenic for animals including a subhuman primate. Churchill and Biggs (1967) showed that a herpes virus (MDHV) was the cause of Marek's disease which is a very common, highly infectious lvmphoid tumour of chickens, and more recently Japanese workers have claimed that MDHV shares a common antigen with EB virus (Ono, Tanable, Naito, Doi, and Kato 1970) . Again, the herpes virus which causes the Lucke renal adenocarcinoma of leopard frogs (Mizell, Toplin, and Isaacs 1969) has been shown to share a common antigen with EB virus (Fink, King, and Mizell, 1968) . And again, Herpes saimiri, which regularly induces a rapidly fatal reticulum cell sarcoma on inoculation into both owl monkeys and marmosets (Melendez et al, 1969 (Melendez et al, , 1970 , has recently been shown capable of inducing acute lymphatic leukaemia in owl monkeys (Melendez, Hunt, Daniel, Blake, and Garcia, 1971 ); incidentally it is worth remarking that H. saimiri thus represents the first DNA leukaemogenic agent.
We have seen that of the four Henle postulates which a suspected human tumour virus must satisfy before it can be termed definitely oncogenic in man, EB virus seems to satisfy three and the fourth is as yet unfulfilled because ethical considerations deprive us of the use of man as a biological model. Attempts have therefore to be made to cross species barriers and to induce tumours not in the natural host of EB virus, man, but in animals.
At this stage, it is worth considering the actual mechanism by which an oncogenic virus transforms a normal cell into a neoplastic one. In the case of DNA oncogenic viruses, the first requirement is the persistence of the viral nucleic acid within the transformed cell. In the case of the herpes DNA oncogenic viruses, a second requirement must be a non-productive infection since productive infection with herpes viruses is invariably a lytic infection. The third requirement is more controversial but many workers today think virus-induced membrane change is the key oncogenic parameter. Such membrane antigen changes are found in all experimental tumours and transformed cells. Regulation of cellular growth, whether hormonal or contactual, must be mediated via receptors on the cellular membrane and these receptors might be so changed in a non-lytic virus infection as to become insensitive to regulation, and, if this non-lylic infection is compatible with cellular division, a neoplastic cell might be the result. Here it would be appropriate to consider these membrane changes in relation to herpes viruses. Roizman (1971) found that in the case of herpes simplex (HSV) infection, viral envelope material was inserted into the cellular membrane and led to differences in social behaviour of the cell; he also found that infection with different herpes simplex virus mutants led to different types of social behaviour, each characteristic of the different mutant. These changes in social behaviour in the infected cells included clump forming of various sizes and adhesiveness, cell fusion, cell paralysis, adsorption of sensitized sheep erythrocytes, etc. Although these cells were lytically infected, it is not difficult to imagine a non-productive, non-lytic herpes virus infection changing the cellular membrane and hence the social behaviour of the cell towards lack of response to growth regulation while allowing the cell to grow and divide. The one provision here for an oncogenic herpes virus is that the membrane change must be early and independent of viral DNA synthesis and late viral functions which always lead to lysis. An experimental model of this last proposition has recently been described by Duff and Rapp (1971) . They used HSV-2 inactivated by ultraviolet light in order to obtain a non-productive non-lytic infection and with this inactivated HSV-2 they transformed hamster cells in vitro, and these non-productive transformed cells not only contained HSV-specific antigens and induced tumours on reimplantation into hamsters but also bore new antigen on their membranes since virus-neutralizing antibodies appeared in the tumour-bearing hamsters.
The EB virus fits very well into the role of oncogenic virus as outlined above and even better into that of herpes DNA oncogenic virus. First we see that EB virus does indeed persist in the form of its nucleic acid within the transformed cell. Secondly, EB virus produces a persistent, latent, non-productive, nonlytic infection in the target cells and this is mirrored exactly by the MDHV and Herpes saimiri tumour systems. Thirdly, EB virus induces the production of membrane antigen which is an early antigen independent of viral DNA synthesis, and these membrane changes may conceivably alter the social behaviour of the cell towards disobedience to growth regulation and this, coupled with cellular viability, as EB virus is a non-lytic virus in the tumour situation, would result in a neoplastic cell.
Two further points of similarity between EB virus and oncogenic animal viruses might here be mentioned. First, EB virus is widely present in human populations and the induction of a tumour must be looked upon as a very unusual effect involving a rare individual out-of the large numbers infected, in the same way as widespread murine and avian tumour viruses initiate neoplasia only in a small minority of infected animals. Secondly, Gerber (1971) (Williams, 1966; Pike, Morrow, Kisuule, and Mafigiri, 1970 
